Filling the need for trusted information on national health issues
STAT: Public funding underwrote much of the development of J&J’s drug for TB, analysis finds “Amid ongoing debate over taxpayer dollars used to generate medicines, a new analysis contends that public investments contributed up to five times more than what Johnson & Johnson (JNJ) spent to develop Sirturo, its groundbreaking…
Health Affairs Blog: Meals As Medicine: Feed The Hungry To Treat The Tuberculosis Pandemic Pranay Sinha, infectious diseases physician and post-doctoral researcher at the Boston University School of Medicine, and Natasha S. Hochberg, infectious diseases physician and associate professor of medicine at the Boston University School of Medicine and associate…
Friends of the Global Fight Against AIDS, Tuberculosis and Malaria: How COVID-19 is affecting the global response to AIDS, tuberculosis and malaria (9/30). Global Citizen: The U.K. Is Set to Become the Largest State Donor to the WHO to Help Fight COVID-19 Helen Lock, content writer at Global Citizen (9/30).…
Devex: High price excludes patients from better treatment for drug-resistant TB “…Johnson & Johnson, which markets bedaquiline under the brand name Sirturo [for the treatment of drug-resistant TB], has been accused of employing unfair tactics in an attempt to retain the drug’s patent and tighten its grip on the monopoly.…
BMJ Opinion: Ensuring continuity of tuberculosis care during the covid-19 crisis Nathaly Aguilera Vasquez, program officer at the McGill International TB Centre at McGill University, and colleagues (6/25). Brookings: Global macroeconomic scenarios of the COVID-19 pandemic Warwick J. McKibbin, nonresident senior fellow for economic studies and co-director of the Climate…
Center for Global Development: Understanding the Impact Of COVID-19 On Essential Medicine Supply Chains Anthony McDonnell, senior policy analyst at CGD, and colleagues (6/17). Global Fund to Fight AIDS, Tuberculosis and Malaria: Global Fund Survey: Majority of HIV, TB and Malaria Programs Face Disruptions as a Result of COVID-19 (6/17).…
